ANXA3 and lung carcinoma: The crosstalk was demonstrated using CAF-CM (CAF-conditioned media) incubation, which increased the ANXA3 level in lung cancer cells, which subsequently enhanced cisplatin resistance by inhibiting cisplatin-induced apoptosis involving ANXA3/JNK signaling [45].